Related Experiment Video
Updated: Feb 25, 2026

11:28
Analytical Techniques for Assaying Nitric Oxide Bioactivity
Published on: June 18, 2012
18.6K
Trimethylamine N-oxide: breathe new life
Saravanan Subramaniam1,2, Craig Fletcher1,2
1Department of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
British Journal of Pharmacology
|July 27, 2017
Summary
Elevated levels of trimethylamine N-oxide (TMAO) are linked to cardiovascular disease risk. This review covers TMAO
Area of Science:
- Biochemistry
- Cardiovascular Science
- Microbiome Research
Background:
- Systemic trimethylamine N-oxide (TMAO) is increasingly implicated in cardiovascular disease pathogenesis.
- TMAO is derived from gut bacterial metabolism of dietary components like choline and L-carnitine.
- Flavin-containing monooxygenase-3 is the primary enzyme responsible for TMAO production in the liver.
Purpose of the Study:
- To review the biosynthesis of TMAO.
- To discuss clinical studies evaluating TMAO as a biomarker for cardiovascular and other diseases.
- To summarize interactions affecting TMAO levels.
Main Methods:
- Literature review of experimental and clinical studies.
- Analysis of TMAO biosynthesis pathways.
- Examination of TMAO's role in various disease states.
Main Results:
- Growing evidence links elevated TMAO to adverse cardiovascular events.
- TMAO is explored as a biomarker for kidney failure, thrombosis, atherosclerosis, obesity, diabetes, and cancer.
- Interactions with various molecules influence circulating TMAO levels.
Conclusions:
- TMAO is a significant factor in cardiovascular disease development.
- TMAO serves as a potential biomarker across multiple disease categories.
- Further research into TMAO modulation is warranted.
Related Concept Videos
2° Amines to N-Nitrosamines: Reaction with NaNO2
5.6K
Secondary amines react with nitrous acid to form N-nitrosamines, as depicted in Figure 1. Nitrous acid, a weak and unstable acid, is formed in situ from an aqueous solution of sodium nitrite and strong acids, such as hydrochloric acid or sulfuric acid, in cold conditions. In the presence of an acid, the nitrous acid gets protonated. The subsequent loss of water results in the formation of the electrophile known as nitrosonium ion.
5.6K
Physical Properties of Amines
4.3K
Amines with low molecular weight are usually gaseous at room temperature, while those with high molecular weight are liquid or solids in nature. Usually, low molecular weight amines have a rotten fish-like smell. Diamines typically have a pungent smell. For instance, cadaverine and putrescine, depicted in Figure 1, are two molecules responsible for decaying tissue.
4.3K
Amines: Introduction
5.9K
Amines are organic derivatives of ammonia. They are formed by replacing one or more ammonia protons with alkyl or aryl groups. Depending upon the number of organyl groups bonded to nitrogen, amines are classified as primary, secondary, or tertiary. Primary amines have one organyl group attached to the nitrogen atom, while secondary and tertiary amines have two and three organyl groups attached to the nitrogen atom, respectively.
5.9K
Drugs Affecting Neurotransmitter Synthesis
2.3K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
2.3K
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
4.0K
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
4.0K
Adrenergic Agonists: Indirect-Acting Agents
2.9K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
2.9K

